{"id":"https://openalex.org/W2017787121","doi":"https://doi.org/10.1055/s-0028-1087989","title":"Practical Syntheses of Enantiomerically Pure Key Intermediates of Opioid Receptor-like 1 (ORL1) Antagonists","display_name":"Practical Syntheses of Enantiomerically Pure Key Intermediates of Opioid Receptor-like 1 (ORL1) Antagonists","publication_year":2009,"publication_date":"2009-03-06","ids":{"openalex":"https://openalex.org/W2017787121","doi":"https://doi.org/10.1055/s-0028-1087989","mag":"2017787121"},"language":"en","primary_location":{"id":"doi:10.1055/s-0028-1087989","doi":"https://doi.org/10.1055/s-0028-1087989","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-0028-1087989","pdf_url":null,"source":{"id":"https://openalex.org/S197964166","display_name":"Synthesis","issn_l":"0039-7881","issn":["0039-7881","1437-210X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Synthesis","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004549315","display_name":"Takashi Yoshizumi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]},{"id":"https://openalex.org/I146399215","display_name":"University of Tsukuba","ror":"https://ror.org/02956yf07","country_code":"JP","type":"education","lineage":["https://openalex.org/I146399215"]}],"countries":["JP","US"],"is_corresponding":false,"raw_author_name":"Takashi Yoshizumi","raw_affiliation_strings":["Merck","University of Tsukuba"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"University of Tsukuba","institution_ids":["https://openalex.org/I146399215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041881204","display_name":"Hideo Kigoshi","orcid":"https://orcid.org/0000-0003-1554-5129","observed_orcids":["https://orcid.org/0000-0003-1554-5129"]},"institutions":[{"id":"https://openalex.org/I146399215","display_name":"University of Tsukuba","ror":"https://ror.org/02956yf07","country_code":"JP","type":"education","lineage":["https://openalex.org/I146399215"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hideo Kigoshi","raw_affiliation_strings":["university of Tsukuba"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"university of Tsukuba","institution_ids":["https://openalex.org/I146399215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111735482","display_name":"Akio Ohno","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Akio Ohno","raw_affiliation_strings":["Merck"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078860532","display_name":"Tomohiro Tsujita","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tomohiro Tsujita","raw_affiliation_strings":["Merck"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108207908","display_name":"Hirobumi Takahashi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hirobumi Takahashi","raw_affiliation_strings":["Merck"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066820686","display_name":"Osamu Okamoto","orcid":"https://orcid.org/0000-0002-8429-1057","observed_orcids":["https://orcid.org/0000-0002-8429-1057"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Osamu Okamoto","raw_affiliation_strings":["Merck"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5050775905","display_name":"Ichiro Hayakawa","orcid":"https://orcid.org/0000-0003-2749-9078","observed_orcids":["https://orcid.org/0000-0003-2749-9078"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ichiro Hayakawa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1612,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.48782493,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"2009","issue":"07","first_page":"1153","last_page":"1162"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13649","display_name":"Advanced Synthetic Organic Chemistry","score":0.4431000053882599,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T13649","display_name":"Advanced Synthetic Organic Chemistry","score":0.4431000053882599,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.27469998598098755,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.07919999957084656,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/opioid-receptor-like-1","display_name":"opioid receptor-like 1","score":0.9160000085830688},{"id":"https://openalex.org/keywords/enantiomerically-pure-intermediates","display_name":"enantiomerically pure intermediates","score":0.8740000128746033},{"id":"https://openalex.org/keywords/asymmetric-synthesis","display_name":"asymmetric synthesis","score":0.621999979019165},{"id":"https://openalex.org/keywords/diastereoselective-reduction","display_name":"diastereoselective reduction","score":0.925000011920929},{"id":"https://openalex.org/keywords/multigram-scale-up","display_name":"multigram scale-up","score":0.7739999890327454},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.800000011920929},{"id":"https://openalex.org/keywords/adverse-cardiovascular-events","display_name":"cardiovascular adverse events","score":0.9210000038146973}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.957573413848877},{"id":"https://openalex.org/C201194858","wikidata":"https://www.wikidata.org/wiki/Q898238","display_name":"Steric effects","level":2,"score":0.6994775533676147},{"id":"https://openalex.org/C40875361","wikidata":"https://www.wikidata.org/wiki/Q2356542","display_name":"Reagent","level":2,"score":0.6863745450973511},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.5999764204025269},{"id":"https://openalex.org/C26517878","wikidata":"https://www.wikidata.org/wiki/Q228039","display_name":"Key (lock)","level":2,"score":0.5368502736091614},{"id":"https://openalex.org/C525849907","wikidata":"https://www.wikidata.org/wiki/Q1096","display_name":"Tin","level":2,"score":0.42321985960006714},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.3926845192909241},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.3334188759326935},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1055/s-0028-1087989","doi":"https://doi.org/10.1055/s-0028-1087989","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-0028-1087989","pdf_url":null,"source":{"id":"https://openalex.org/S197964166","display_name":"Synthesis","issn_l":"0039-7881","issn":["0039-7881","1437-210X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Synthesis","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.6240000128746033,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G6756987936","display_name":"Structure-activity relationship study of hatermalides by using medicinal chemistry","funder_award_id":"21510221","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"}],"funders":[{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2318066256","https://openalex.org/W1990781484","https://openalex.org/W2041006445","https://openalex.org/W2769632396","https://openalex.org/W2334478455","https://openalex.org/W3029994575","https://openalex.org/W2555959555","https://openalex.org/W2335378681","https://openalex.org/W2067111532","https://openalex.org/W2077516083"],"abstract_inverted_index":{"Practical":[0],"syntheses":[1],"of":[2,7,21,24,36,43,73],"enantiomerically":[3],"pure":[4],"key":[5,26,46],"intermediates":[6],"opioid":[8],"receptor-like":[9],"1":[10],"(ORL1)":[11],"antagonists":[12],"are":[13],"described.":[14],"Our":[15,57],"synthetic":[16],"methodology":[17,58],"features":[18],"the":[19,34,41,45,65,71],"preparation":[20],"multigram":[22,68],"quantities":[23,69],"seven-membered":[25],"intermediate":[27],"(-)-3":[28],"and":[29],"six-membered":[30],"one":[31],"(-)-4":[32],"without":[33],"use":[35],"toxic":[37],"tin":[38],"reagents.":[39],"In":[40],"case":[42,72],"(-)-3,":[44],"step":[47],"involved":[48],"diastereoselective":[49],"reduction":[50],"using":[51],"a":[52],"sterically":[53],"hindered":[54],"reducing":[55],"reagent.":[56],"allows":[59],"for":[60],"facile":[61],"scale-up":[62],"to":[63],"afford":[64],"products":[66],"in":[67,85],"[in":[70],"(-)-4,":[74],">100-g":[75],"quantities).":[76],"These":[77],"convenient":[78],"approaches":[79],"facilitate":[80],"structure-activity":[81],"relationship":[82],"studies":[83],"including":[84],"vivo":[86],"cardiovascular":[87],"adverse":[88],"effects.":[89]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2025-11-06T03:46:38.306776","created_date":"2016-06-24T00:00:00"}